Wild-Type MIC Distributions and Epidemiologic Cutoff Values for Fluconazole and Candida: Time for New Clinical Breakpoints?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Link
http://link.springer.com/content/pdf/10.1007/s12281-010-0022-x.pdf
Reference41 articles.
1. Maertens JA: History of the development of azole derivatives. Clin Microbiol Infect 2004, 10(Suppl 1):1–10.
2. Sheehan DJ, Hitchcock CA, Sibley CM: Current and emerging azole antifungal agents. Clin Microbial Rev 1999, 12:40–79.
3. •• Pappas PG, Kauffman CA, Andes D, et al.: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503–535. These are the most recent clinical guidelines for the management of all forms of candidiasis.
4. Antoniadou A, Torres HA, Lewis RE, et al.: Candidemia in a tertiary care center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine 2003, 82:309–321.
5. Arikan S, Akova M, Hayran M, et al.: Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis. Clin Infect Dis 1998, 26:903–908.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Amphidinium spp. as a Source of Antimicrobial, Antifungal, and Anticancer Compounds;Life;2023-11-04
2. Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms;Brazilian Journal of Microbiology;2022-10-28
3. Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database;Medical Mycology;2015-11-21
4. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values;Diagnostic Microbiology and Infectious Disease;2013-09
5. In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values;Annals of Laboratory Medicine;2013-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3